Assignee
AFFINIUM PHARM INC
CA·30 granted patents·27 pending applications·623 citations·filing 1997–2013
Top patents by PatentIndex Score
57 records- 0197US7250424B2Fab I inhibitorsAFFINIUM PHARM INC·Filed 2005·Granted Jul 31, 2007·36 cites·3 claims
- 0295US7741339B2Fab I inhibitorsAFFINIUM PHARM INC·Filed 2007·Granted Jun 22, 2010·15 cites·4 claims
- 0395US7524843B2Fab I inhibitorsAFFINIUM PHARM INC·Filed 2007·Granted Apr 28, 2009·28 cites·14 claims
- 0495US6730684B1Fab I inhibitorsAFFINIUM PHARM INC·Filed 2000·Granted May 4, 2004·47 cites·17 claims
- 0594US7049310B2Fab I inhibitorsAFFINIUM PHARM INC·Filed 2002·Granted May 23, 2006·35 cites·4 claims
- 0694US6762201B1Fab I inhibitorsAFFINIUM PHARM INC·Filed 2000·Granted Jul 13, 2004·39 cites·9 claims
- 0794US6673941B2Disubstituted imidazoles useful in the treatment of bacterial infectionsAFFINIUM PHARM INC·Filed 2003·Granted Jan 6, 2004·36 cites·6 claims
- 0893US7790716B2Fab I inhibitorsAFFINIUM PHARM INC·Filed 2009·Granted Sep 7, 2010·19 cites·3 claims
- 0993US6846819B1Fab I inhibitorsAFFINIUM PHARM INC·Filed 2000·Granted Jan 25, 2005·40 cites·12 claims
- 1092US6573272B1Antibacterial compoundsAFFINIUM PHARM INC·Filed 2000·Granted Jun 3, 2003·42 cites·4 claims
- 1190US7557125B2Fab I inhibitorsAFFINIUM PHARM INC·Filed 2004·Granted Jul 7, 2009·28 cites·5 claims
- 1290US6951729B1High throughput screening method for biological agents affecting fatty acid biosynthesisAFFINIUM PHARM INC·Filed 2000·Granted Oct 4, 2005·38 cites·17 claims
- 1390US6765005B2Fab I inhibitorsAFFINIUM PHARM INC·Filed 2002·Granted Jul 20, 2004·33 cites·10 claims
- 1489US7879872B2Compositions comprising multiple bioactive agents, and methods of using the sameAFFINIUM PHARM INC·Filed 2005·Granted Feb 1, 2011·11 cites·4 claims
- 1588US7176299B2CompoundsAFFINIUM PHARM INC·Filed 2005·Granted Feb 13, 2007·3 cites·4 claims
- 1688US7048926B2Methods of agonizing and antagonizing FabKAFFINIUM PHARM INC·Filed 2003·Granted May 23, 2006·38 cites·20 claims
- 1788US6821746B2Methods of screening for FabK antagonists and agonistsAFFINIUM PHARM INC·Filed 2001·Granted Nov 23, 2004·28 cites·12 claims
- 1886US8901105B2Prodrug derivatives of (E)-N-methyl-N-((3-M ethylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamideAFFINIUM PHARM INC·Filed 2013·Granted Dec 2, 2014·8 cites·22 claims
- 1985US6964970B2Antibacterial compoundsAFFINIUM PHARM INC·Filed 2003·Granted Nov 15, 2005·20 cites·20 claims
- 2082US7790709B2Heterocyclic compounds, methods of making them and their use in therapyAFFINIUM PHARM INC·Filed 2003·Granted Sep 7, 2010·12 cites·14 claims
- 2182US7033795B2FabK variantAFFINIUM PHARM INC·Filed 2002·Granted Apr 25, 2006·9 cites·13 claims
- 2279US8895545B2Acrylamide derivatives as Fab I inhibitorsAFFINIUM PHARM INC·Filed 2012·Granted Nov 25, 2014·2 cites·20 claims
- 2375US7250285B2Purified polypeptides from Streptococcus pneumoniaeAFFINIUM PHARM INC·Filed 2006·Granted Jul 31, 2007·1 cites·4 claims
- 2475US6995254B1Polynucleotide encoding the enoyl-acyl carrier protein reductase of Staphylococcus aureus, FAB IAFFINIUM PHARM INC·Filed 1997·Granted Feb 7, 2006·34 cites·8 claims
- 2570US7601526B2Purified FabI polypeptides from Fransicella tularensisAFFINIUM PHARM INC·Filed 2006·Granted Oct 13, 2009·3 cites·17 claims
- 2670US7422749B2CompoundsAFFINIUM PHARM INC·Filed 2007·Granted Sep 9, 2008·0 cites·6 claims
- 2759US6797523B2Methods for systematic identification of protein—protein interactionsAFFINIUM PHARM INC·Filed 2000·Granted Sep 28, 2004·7 cites·19 claims
- 2856US7056697B2FabK variantAFFINIUM PHARM INC·Filed 2002·Granted Jun 6, 2006·0 cites·2 claims
- 2956US2005214918A1Novel purified polypeptides from streptococcus pneumoniaeAFFINIUM PHARM INC·Filed 2004·Application pending·0 cites
- 3055US2005112713A1Methods of using Fab I and compounds modulating Fab I activityAFFINIUM PHARM INC·Filed 2004·Application pending·0 cites
- 3154US6753172B1FabIAFFINIUM PHARM INC·Filed 1999·Granted Jun 22, 2004·11 cites·13 claims
- 3254US2006052941A1Crystal of bacterial core RNA polymerase and methods of use thereofAFFINIUM PHARM INC·Filed 2005·Application pending·0 cites
- 3352US2005221462A1Novel purified polypeptides from pseudomonas aeruginosaAFFINIUM PHARM INC·Filed 2004·Application pending·0 cites
- 3450US2003104509A1Device and method for the determination of protein domain boundariesAFFINIUM PHARM INC·Filed 2002·Application pending·0 cites
- 3548US2014107106A1Therapeutic agents, and methods of making and using the sameAFFINIUM PHARM INC·Filed 2013·Application pending·0 cites
- 3647US2005079526A1Methods and apparatuses for characterizing refolding and aggregation of biological moleculesAFFINIUM PHARM INC·Filed 2004·Application pending·0 cites
- 3745US2006079669A1Crystal structures of NH3-dependent NAD synthetasesAFFINIUM PHARM INC·Filed 2005·Application pending·0 cites
- 3844US2005187718A1Novel purified polypeptides from Streptococcus pneumoniaeAFFINIUM PHARM INC·Filed 2004·Application pending·0 cites
- 3943US7799547B2Purified polypeptides from Staphylococcus aureusAFFINIUM PHARM INC·Filed 2006·Granted Sep 21, 2010·0 cites·1 claims
- 4043US2005214773A1Novel purified polypeptides from bacteriaAFFINIUM PHARM INC·Filed 2004·Application pending·0 cites
- 4142US2007010949A1Crystal structures of YHHF polypeptidesAFFINIUM PHARM INC·Filed 2005·Application pending·0 cites
- 4242US2005181464A1Novel purified polypeptides from bacteriaAFFINIUM PHARM INC·Filed 2004·Application pending·0 cites
- 4342US2005181388A1Novel purified polypeptides from bacteriaAFFINIUM PHARM INC·Filed 2004·Application pending·0 cites
- 4442US2005158732A1Novel purified polypeptides from Streptococcus pneumoniaeAFFINIUM PHARM INC·Filed 2004·Application pending·0 cites
- 4541US2005164362A1Novel purified polypeptides from pseudomonas aeruginosaAFFINIUM PHARM INC·Filed 2004·Application pending·0 cites
- 4641US2007048814A1Novel Purified dihydrodipicolinate synthase polypeptides and structures thereofAFFINIUM PHARM INC·Filed 2005·Application pending·0 cites
- 4741US2005245728A1Novel purified polypeptides from Pseudomonas aeruginosaAFFINIUM PHARM INC·Filed 2004·Application pending·0 cites
- 4839US2006078922A1Novel purified polypeptides from haemophilus influenzaeAFFINIUM PHARM INC·Filed 2005·Application pending·0 cites
- 4939US2007004020A1Crystal structures of aspartate semialdehyde dehydrogenasesAFFINIUM PHARM INC·Filed 2005·Application pending·0 cites
- 5039US2006078974A1Novel purified hydroxymethylglutaryl-CoA reductases and structures thereofAFFINIUM PHARM INC·Filed 2005·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when AFFINIUM PHARM INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →